Evoworks Bio at the World Orphan Drug Congress 2026

We were thrilled to take the EvoNode platform to the World Orphan Drug Congress 2026, one of the most important gatherings in rare disease drug development.

Rare disease programs face some of the steepest production challenges in biologics: small patient populations, tight timelines, and no margin for error. These are exactly the barriers Evoworks Bio was built to remove. Our mission is to make scalable, reliable cell culture production accessible to the teams working hardest to get life-changing therapies to patients who need them most.

Having a booth at WODC 2026 gave us the chance to connect directly with the people on the front lines of that work. The conversations we had reinforced what we already believe: the infrastructure for rare disease production needs to catch up with the science, and EvoNode is here to help close that gap.

Thank you to everyone who stopped by. We left energized and more committed than ever to the work ahead.